NeuSpera
2013
FOUNDED
PRIVATE
STATUS
Series B
LATEST DEAL TYPE
$26M
LATEST DEAL AMOUNT
6
INVESTORS
Description
Developer of miniaturized injectable neuromodulation devices designed to deliver a liberating alternative treatment. The company's miniaturized injectable neuromodulation devices include implantable neuromodulation devices that use mid-field powering techniques which seek to improve the lives of patients suffering from chronic illness by judging the symptoms, enabling patients to get advanced neuromodulation therapy for their disease, to recover faster.
Website
Formerly Known As
Vivonda Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
- 2841 Junction Avenue
- Suite 101
- San Jose, CA 95134
- United States
+1 (888) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore NeuSpera’s full profile, request a free trial.
NeuSpera Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 24-Jan-2018 | $26M | 000.00 | 0000 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A) | 26-Apr-2016 | 00.000 | 00.00 | 000.00 | Completed | Startup |
| 1. Angel (individual) | $1M | $1M | Completed | Startup |
NeuSpera Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
NeuSpera Competitors (26)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioWave | Venture Capital-Backed | Norwalk, CT | 00 | 00.000 | 00000000000 | 00.000 |
| 000000000 | Corporation | Berlin, Germany | ||||
| 000000 | Formerly VC-backed | Rydalmere, Australia | 00 | 000.00 | 000000000 | 000.00 |
| 000000000 | Venture Capital-Backed | Netanya, Israel | 00 | 0000 | 00000000000 | 0000 |
| 000000 0000000 | Venture Capital-Backed | Willoughby Hills, OH | 00 | 000.00 | 00000000000 | 000.00 |
NeuSpera Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| 6 Dimensions Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Alumni Ventures Group | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Delta Capital | Growth/Expansion | Minority | 000 0000 | 000000 0 | ||
| Purple Arch Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Action Potential Venture Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
NeuSpera Executive Team (5)
NeuSpera Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Ching Zhu Ph.D | 6 Dimensions Capital | Board Member | 000 0000 | |
| Imran Eba | Action Potential Venture Capital | Board Member | 000 0000 | |
| Juan-Pablo Mas | Action Potential Venture Capital | Board Observer | 000 0000 | |
| Milton Morris Ph.D | NeuSpera | President, Board Member & Chief Executive Officer | 000 0000 | |
| Mudit Jain Ph.D | Self | Board Member | 000 0000 |